T

Tohoku Medical and Pharmaceutical University Hospital | Center for Clinical Research Promotion and Development

Research site

(Unclaimed)

Location

1-12-1 Fukumuro, Miyagino-ku, Sendai City, Miyagi, Japan, Sendai, Miyagi, Japan

Site insights

Top conditions

Top treatments

Clarithromycin

Androgen

Lumicitabine

Abiraterone

Felzartamab

Docetaxel

Bedaquiline

Ustekinumab

Enzalutamide

Molidustat

Parent organization

This site is a part of Tohoku Medical and Pharmaceutical University Hospital

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Study of E6742 in Participants With Systemic Lupus Erythematosus

The main purpose of the study is to demonstrate the efficacy based on dose response of E6742 compared with placebo as defined by the proportion of pa...

Enrolling

Systemic Lupus Erythematosus

Other: Placebo

Drug: E6742

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).The main aim of the s...

Enrolling

Psoriatic Arthritis

Drug: Placebo

Drug: Zasocitinib

Locations recently updated

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) (PREVAIL)

In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). IgAN is a kidney di...

Enrolling

Immunoglobulin A Nephropathy (IgAN)

Drug: Felzartamab

Drug: Placebo